SCHEMBL863004

SCHEMBL863004

CC(=O)N(C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18275146 0.96 LMNA (0.39)
SCHEMBL28102523 0.96
SCHEMBL30581182 0.76
SCHEMBL30581185 0.76
SCHEMBL2415 0.76
SCHEMBL173293 0.76
SCHEMBL4820393 0.76
SCHEMBL1925147 0.76 ALDH1A1 (0.50)
SCHEMBL1190178 0.76
SCHEMBL1332099 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 274 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117916215-A Indene compound, pharmaceutical composition thereof and therapeutic application thereof 藤济(厦门)生物医药科技有限公司 2024-04-19 CN claimed
US-20170100352-A1 Methods for treating or preventing neuroinflammation or autoimmune diseases ELFORD HOWARD L (US) 2017-04-13 US claimed
EP-2030615-A2 Ribonucleotide reductase inhibitors for use in the treatment or prevention of neuroinflammatory or autoimmune diseases ELFORD, Howard L. (US) 2009-03-04 EP claimed
US-20090047250-A1 Methods for treating or preventing neuroinflammation or autoimmune diseases ELFORD HOWARD L 2009-02-19 US claimed
EP-1651643-A4 BICYCLIC COMPOUNDS AND COMPOSITIONS AS PDF INHIBITORS IRM LLC (BM) 2008-10-08 EP claimed
EP-1877398-A1 QUINAZOLINE DERIVATIVES AS EGF AND/OR ERBB2 TYROSINE KINASE INHIBITORS AstraZeneca AB (SE) 2008-01-16 EP claimed
US-20070259852-A1 BICYCLIC COMPOUNDS AND COMPOSITIONS AS PDF INHIBITORS IRM LLC 2007-11-08 US claimed
US-7253164-B2 Bicyclic compounds and compositions as PDF inhibitors IRM LLC (BM) 2007-08-07 US claimed
WO-2006117523-A1 QUINAZOLINE DERIVATIVES AS EGF AND/OR ERBB2 TYROSINE KINASE INHIBITORS ASTRAZENECA AB (SE) 2006-11-09 WO claimed
EP-1651643-A2 BICYCLIC COMPOUNDS AND COMPOSITIONS AS PDF INHIBITORS IRM, LLC (BM) 2006-05-03 EP claimed
WO-2001030979-A1 PRIMARY N-HYDROXYLAMINES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2001-05-03 WO claimed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US claimed
US-5756530-A NON-STEROIDAL ANTIINFLAMMATORY AGENTS WITH REDUCED SIDE EFFECTS G. D. SEARLE & CO. (US) 1998-05-26 US claimed
US-5646319-A Synthesis of N-acyl-N-alkylcarboxylates THE PROCTER & GAMBLE COMPANY (US) 1997-07-08 US claimed
EP-0559677-B1 HYDROXAMIC ACIDS FOR PREVENTING REPERFUSION INJURY BRITISH TECH GROUP (GB) 1996-09-11 EP claimed
US-5506266-A CONTROLS FREE RADICAL INDUCED DAMAGE ARISING FROM MYOCARDIAL INFRACTION OR STROKE, PERTICULARYL HEART DAMAGE BRITISH TECHNOLOGY GROUP LIMITED (GB) 1996-04-09 US claimed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US claimed
US-5447934-A Anti-allergic thiadiazolo [4,3-a]pyridine derivatives BOEHRINGER MANNHEIM GMBH (DE) 1995-09-05 US claimed
EP-0559677-A1 HYDROXAMIC ACIDS FOR PREVENTING REPERFUSION INJURY. BRITISH TECH GROUP (GB) 1993-09-15 EP claimed
WO-1992008453-A1 HYDROXAMIC ACIDS FOR PREVENTING REPERFUSION INJURY BRITISH TECHNOLOGY GROUP LTD (GB) 1992-05-29 WO claimed